Rare diseases

Agent Capital is a healthcare venture capital firm focused on novel technologies and therapeutics that address unmet patient need.

Ananda Impact Ventures is the leading impact venture capital fund with a pan-European investment remit, managing ca. €200 million in four Core Impact Funds, with backing from notable institutional and private investors.

Sanofi Ventures is the corporate venture capital arm of Sanofi. They invest in top-tier biotech and digital health companies focusing on improving patient care and transforming healthcare. Their investments span from Seed to Series B and beyond, offering portfolio companies access to Sanofi's expertise.

Syncona is a FTSE250 company focused on founding, building, and funding healthcare companies. They aim to deliver transformational treatments for patients in areas of high unmet need, building a diversified portfolio of 20-25 globally leading life science businesses.